Pulmonary Disease in Houston, TX
159 verified pulmonary disease doctors in Houston. Page 1 of 3.
Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Jamal Razzack, MD
Pulmonary Disease
CMS Open Payments· $1,698 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,698
Total received
80
Transactions
18
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 84th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Jamal Razzack do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Raul Sanchez Leon, MD
Pulmonary Disease
CMS Open Payments· $112.68 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$112.68
Total received
4
Transactions
2
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 59th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Raul Sanchez Leon do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Victor Salcedo, MD
Pulmonary Disease
CMS Open Payments· $1,615 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,615
Total received
67
Transactions
18
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 84th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Victor Salcedo do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Robert Solis, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Mohsin Bajwa, MD
Pulmonary Disease
CMS Open Payments· $1,368 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,368
Total received
96
Transactions
15
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 82th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Mohsin Bajwa do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Salah Ghobrial, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Nelson Fernandez, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Kenneth Toppell, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Muhammad Hanif, MD
Pulmonary Disease
CMS Open Payments· $514.39 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$514.39
Total received
27
Transactions
12
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 74th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Muhammad Hanif do not imply any wrongdoing. Many are meals, education, or research support.
Dr. George Keith, MD
Pulmonary Disease
CMS Open Payments· $3,543 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$3,543
Total received
183
Transactions
23
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 90% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to George Keith do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Bhakti Gidvani, MD
Pulmonary Disease
CMS Open Payments· $697.18 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$697.18
Total received
24
Transactions
14
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 76th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Bhakti Gidvani do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Robert Wang, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Phuong-Dung Nguyen, MD
Pulmonary Disease
CMS Open Payments· $8,763 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$8,763
Total received
121
Transactions
18
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 92% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Phuong-Dung Nguyen do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Fidaa Shaib, MD
Pulmonary Disease
CMS Open Payments· $23.57 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$23.57
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is on the lower end — around the 49th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Fidaa Shaib do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Divina Tuazon, MD
Pulmonary Disease
CMS Open Payments· $202.94 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$202.94
Total received
2
Transactions
2
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 65th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Divina Tuazon do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Tehmina Badar, MD
Pulmonary Disease
CMS Open Payments· $1,607 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,607
Total received
77
Transactions
22
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 84th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Tehmina Badar do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Martin Kaplan, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Alexander Stadnyk, MD
Pulmonary Disease
CMS Open Payments· $27,020 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$27,020
Total received
60
Transactions
9
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 95% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Alexander Stadnyk do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Ivan Rosas, MD
Pulmonary Disease
CMS Open Payments· $442,597 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$442,597
Total received
56
Transactions
7
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 99% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Ivan Rosas do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Neeta Singla, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Juan Barriga, MD
Pulmonary Disease
CMS Open Payments· $14.20 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$14.20
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is on the lower end — around the 46th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Juan Barriga do not imply any wrongdoing. Many are meals, education, or research support.
Dr. James Herlihy, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Srinivas Vodnala, MD
Pulmonary Disease
CMS Open Payments· $56,173 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$56,173
Total received
115
Transactions
22
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 97% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Srinivas Vodnala do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Brian Walker, MD
Pulmonary Disease
CMS Open Payments· $35.07 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$35.07
Total received
2
Transactions
2
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 52th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Brian Walker do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Jihad Youssef, MD
Pulmonary Disease
CMS Open Payments· $479.77 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$479.77
Total received
18
Transactions
11
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 73th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Jihad Youssef do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Shahram Moghtader, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Thinh Vo, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Robert Salazar, MD
Pulmonary Disease
CMS Open Payments· $3,661 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$3,661
Total received
143
Transactions
24
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 90% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Robert Salazar do not imply any wrongdoing. Many are meals, education, or research support.
Dr. John Fetter, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Alex Lechin, MD
Pulmonary Disease
CMS Open Payments· $1,418 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,418
Total received
73
Transactions
16
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 83th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Alex Lechin do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Anatoli Krasko, MD
Pulmonary Disease
CMS Open Payments· $464.02 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$464.02
Total received
12
Transactions
6
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 73th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Anatoli Krasko do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Rolando Rumbaut, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Kanta Velamuri, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Philip Pirtle, MD
Pulmonary Disease
CMS Open Payments· $1,663 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,663
Total received
79
Transactions
18
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 84th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Philip Pirtle do not imply any wrongdoing. Many are meals, education, or research support.
Dr. George Delclos, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Manuel Bloom, MD
Pulmonary Disease
CMS Open Payments· $2,941 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$2,941
Total received
123
Transactions
24
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 89th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Manuel Bloom do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Ghassan Noureddine, MD
Pulmonary Disease
CMS Open Payments· $1,506 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,506
Total received
70
Transactions
15
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 83th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Ghassan Noureddine do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Nada Eldairi, MD
Pulmonary Disease
CMS Open Payments· $454.01 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$454.01
Total received
14
Transactions
8
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 72th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Nada Eldairi do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Amelia Ng, MD
Pulmonary Disease
CMS Open Payments· $860.75 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$860.75
Total received
42
Transactions
8
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 78th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Amelia Ng do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Roberto Adachi, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Amir Sharafkhaneh, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Jennifer Cunningham-Farbstein, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Kenneth Unger, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Julio Shahar, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Atiya Dhala, MD
Pulmonary Disease
CMS Open Payments· $67.09 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$67.09
Total received
2
Transactions
2
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 55th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Atiya Dhala do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Matt Khoshnevis, MD
Pulmonary Disease
CMS Open Payments· $18.60 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$18.60
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is on the lower end — around the 48th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Matt Khoshnevis do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Carlos Jimenez, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Burton Dickey, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Lara Bashoura, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Scott Evans, MD
Pulmonary Disease
CMS Open Payments· $27.77 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$27.77
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 50th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Scott Evans do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Rodolfo Morice, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Diwaker Balachandran, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Farrah Kheradmand, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Amir Onn, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Suhair Mugawish, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Vickie Shannon, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Mayank Patel, MD
Pulmonary Disease
CMS Open Payments· $705.44 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$705.44
Total received
34
Transactions
10
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 76th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Mayank Patel do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Georgie Eapen, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Krishna Chandrasekhar, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Kalpalatha Guntupalli, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.